Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 January, 2019 01:08 IST
Vivimed Labs acquires Hungary based CDMO biz Soneas
Source: IRIS | 16 May, 2018, 12.14PM
Comments  |  Post Comment

Vivimed Labs Spain S.L, the parent of UQUIFA S.A, has signed definitive agreements to facilitate the acquisition of SONEAS, a Budapest (Hungary) head quartered CDMO company, focussed on the Inriovator Pharmaceutical and Fine Chemical sectors.

The business has been acquired from Lochlomond and Euroventures which are both based out of Hungary. SONEAS has for the year 2017, reported revenues of Euro 12.2 million.

The acquisition broadens UQUIFA's market offering in the CDMO space by enhancing its ability to now undertake preclinical, phase I, 11 and III NCE project development. These projects can then also potentially feed into UQUIFA's existing cGMP inspected and approved manufacturing facilities in Spain and Mexico, creating a high-value project pipeline.

Shares of the company gained Rs 2.1, or 3.18%, to trade at Rs 68.10. The total volume of shares traded was 73,620 at the BSE (12.01 p.m., Wednesday).





Vivimed Labs Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Lupin receives FDA approval for Levothyroxine Sodium Tablets USP - 21-Jan-2019 17:08
Zydus gets tentative approval from USFDA for Esomeprazole Magnesium Delayed-Release - 21-Jan-2019 16:10
SBI witnessed overwhelming response for its USD 1.25 mn bonds issue - 21-Jan-2019 10:57
HDFC Bank Q3 earnings grow 20% to Rs 55.85 bn - 21-Jan-2019 10:54
BHEL and Libcoin in dialogue to build India's first lithium ion factory - 21-Jan-2019 10:32
BHEL to set up solar electric vehicle chargers along Delhi-Chandigarh highway - 21-Jan-2019 10:28
Wockhardt receives USFDA approval for Leukemia drug - 21-Jan-2019 10:20
Ratnamani Metals & Tubes receives order worth Rs 2 bn - 18-Jan-2019 15:59
Aurobindo Pharma to acquire portfolio of oncology injectables products - 18-Jan-2019 13:47
Reliance Ind Q3 earnings up 8.8%; GRM's at USD 8.8/bbl - 18-Jan-2019 13:08
Announcement under Regulation 30 (LODR)-Change in Directorate - 18-Jan-2019 11:14
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer